|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash lease expense | |||||
| Amortization of contract acquisition costs | |||||
| Stock-based compensation expense | |||||
| Loss on extinguishment of debt | |||||
| Remeasurement of warrant liability | |||||
| Other, net | |||||
| Change in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Contract acquisition costs | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Operating lease liabilities | |||||
| Accrued expenses and other liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Purchases of intangible assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Payments of deferred offering costs for registration statement | |||||
| Proceeds from shares issued in connection with employee stock purchase plan | |||||
| Shares repurchased for tax withholdings on vesting of restricted stock | |||||
| Debt issuance proceeds (costs), net | |||||
| Repayment of debt and related fees | |||||
| Proceeds from short-term payable financing | |||||
| Payments on short-term payable financing | |||||
| Proceeds from exercise of stock options | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net decrease in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid for income taxes, net of refunds | |||||
| Cash paid (received) for income taxes, net | |||||
| Cash paid for interest | |||||
| Non-cash investing and financing activities | |||||
| Operating lease right-of-use assets obtained for lease liabilities | |||||
| Purchases of property and equipment included in accounts payable and lease liabilities | |||||
| Stock-based compensation capitalized as internal-use software | |||||
| Debt issuance costs in accounts payable and accrued liabilities | |||||
| Deferred offering costs for registration statement in accounts payable and accrued liabilities | |||||
| Issuance of warrants in connection with credit facility | |||||
Loading...